Skip to main content
#
 
site map
contact
Our History

The International Institute of Applied Immunology started treating Cancer patients with Full Spectrum Specifc Immunotherapy in 1964.  In those more than fifty four years of experience, our research into immunotherapy has evolved and so has the number of happy patients.    During those five decades Peru has undergone a variety of complex political and economic challenges that have made it very difficult to progress.  During that time our focus has always been to take care of the patients that sought our help.   Although we have always had the aim of publishing this work and proving its effectiveness in the medical and scientific community, we have not had the resources to undertake such lofty goals. In our eyes, treating the patients in front of us has always taken priority.   Now in a time of easy world-wide communications and global awareness we are making this treatment available to international patients and perhaps we will be able to raise the awareness about the effectiveness of Full Spectrum Specific Immunotherapy in the treatment of various forms of Cancer.   

Types of Cancer Successfully Treated with Full Spectrum Specific Immunotherapy

Since the very first application of Full Spectrum Specific Immunotherapy in 1964 we have accumulated experience in the treatment of the following types of Cancer with very positive results.  The fact that a certain type of cancer is not in this list does not mean it cannot be treated with Full Spectrum Specific Immunotherapy, only that we have not encountered patients with that type of cancer yet.

  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
    • Anaplastic Astrocytoma
    • Brain Stem Glioma
    • Glyoblastoma
    • Malign Ependymoma
  • Breast Cancer
    • Adenoid Cystic Carcinoma of the Breast
    • Ductal Carcinoma In Situ(DCIS)
    • Invasive Breast Cancer(NST)
    • Invasive Lobular Breast Cancer
    • Lobular Carcinoma In Situ (LCIS)
    • Papillary Breast Cancer
    • Triple Negative (TNBC)
    • Tubular Breast Cancer
  • Colon or Colorectal Cancer
  • Endometrial Cancer
Limited Availability

Full Spectrum Specific Immunotherapy requires the production of specific medicine for each patient based on the patients specific pathology.  The process to produce this medicine takes fourteen days and it cannot be shortened by efficiencies of scale.  This means it is not possible to grow it quickly into mass production.  It also means that it does not attract the profit mentality of large corporate interests.  The end result is that there is a limit to the number of patients that can be treated each month.  So if you are interested, we urge you to act quickly. 

  • Epidermoid Carcinoma
  • Esophageal Cancer
  • Ewings Sarcoma
  • Hepatocarcinoma (Liver)
  • Leukemia
  • Limphoma
  • Lung Cancer
  • Melanoma
  • Multiple Myeloma
  • Osteosarcoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer (Kidney)
  • Stomach Cancer
  • Throat Cancer
  • Thyroid Cancer
TESTIMONIALS

We have successfully treated hundreds of patients over the years.  Out of gratitude, some of them have kindly agreed to let us share their stories with you.  If you would like to see some examples of our successful treatments using Full Spectrum Specific Immunotherapy, please click te link below.

    EMINDES Cancer

    EMINDES Cancer is based in Lima, Peru.  We have been successfully applying Immunology to Cancer patients for more than fifty years.

    EMINDES CANCEER
    Jiron Estados Unidos 775
    Jesus Maria
    Lima 33
    Peru

    Peru

    .

    Build your own website
    WebStudio Website Builder